Efficacy of cladribine tablets 3.5 mg/kg in patients with relapsing multiple sclerosis aged above and below 45 years; clarity and clarity extension

Autor:	Gavin Giovannoni, B. Keller, Kottil Rammohan, Stuart D. Cook, Patrick Vermersch, P Soelberg-Sorensen, E. Verdun di Cantogno
Rok vydání:	2019
Předmět:	medicine.medical_specialty business.industry Multiple sclerosis medicine.disease law.invention Neurology law Internal medicine CLARITY Medicine In patient Neurology (clinical) business Cladribine medicine.drug
Zdroj:	Journal of the Neurological Sciences. 405:177-178
ISSN:	0022-510X
DOI:	10.1016/j.jns.2019.10.1122
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c8448a9fb55036c6571cbb7e92109ae8 https://doi.org/10.1016/j.jns.2019.10.1122 Zobrazit plný text záznamu Full Text from ScienceDirect